US Stock MarketDetailed Quotes

Nymox Pharmaceutical (NYMXF)

Watchlist
  • 0.0101
  • +0.0001+1.00%
15min DelayClose Jul 24 13:22 ET
954.86KMarket Cap-0.20P/E (TTM)

Nymox Pharmaceutical (NYMXF) Cash Flow

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2024/Q4
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
2021/Q2
2021/Q1
2020/Q4
2020/Q3
2020/Q2
2020/Q1
2019/Q4
2019/Q3
2019/Q2
Operating Cash Flow
+20.07%-717.00K
+28.18%-897.00K
+3.29%-1.26M
-158.38%-909.00K
+76.52%-988.00K
+44.46%-1.25M
+56.47%-1.31M
+181.86%1.56M
-57.62%-4.21M
-33.55%-2.25M
+25.37%-3.00M
+12.11%-1.90M
-23.05%-2.67M
+7.12%-1.68M
-112.47%-4.02M
-1.50%-2.16M
-36.16%-2.17M
-7.47%-1.81M
+20.20%-1.89M
-11.62%-2.13M
Net cash flow from continuing operations
+20.07%-717.00K
+28.18%-897.00K
+3.29%-1.26M
-158.38%-909.00K
+76.52%-988.00K
+44.46%-1.25M
+56.47%-1.31M
+181.86%1.56M
-57.62%-4.21M
-33.55%-2.25M
+25.37%-3.00M
+12.11%-1.90M
-23.05%-2.67M
+7.12%-1.68M
-112.47%-4.02M
-1.50%-2.16M
-36.16%-2.17M
-7.47%-1.81M
+20.20%-1.89M
-11.62%-2.13M
Net Income from Continuing Operations
+83.86%-857.00K
-296.64%-5.31M
+30.52%-1.04M
-182.84%-1.11M
+72.73%-1.39M
+52.35%-1.34M
+54.79%-1.49M
+133.58%1.34M
-108.53%-5.09M
-38.63%-2.81M
+20.64%-3.30M
-35.71%-3.99M
+6.73%-2.44M
+24.56%-2.03M
-68.87%-4.16M
+42.85%-2.94M
+8.89%-2.62M
+1.21%-2.69M
+11.82%-2.46M
-112.65%-5.14M
Depreciation & Depletion & Amortization
-100.00%0.00
-81.97%11.00K
-32.79%41.00K
-7.94%58.00K
-7.81%59.00K
-4.69%61.00K
-3.17%61.00K
+0.00%63.00K
+0.00%64.00K
+4.92%64.00K
-4.55%63.00K
-11.27%63.00K
-7.25%64.00K
-30.68%61.00K
+6.45%66.00K
+4.41%71.00K
-80.12%69.00K
+4300.00%88.00K
+6100.00%62.00K
--68.00K
Other Non-Cash Items
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
----
Change in Working Capital
-102.64%-19.00K
+907.87%719.00K
-406.59%-279.00K
+148.68%111.00K
-62.55%270.00K
+60.27%-89.00K
+49.18%91.00K
-138.06%-228.00K
+225.17%721.00K
-376.60%-224.00K
+119.93%61.00K
+121.85%599.00K
-149.35%-576.00K
-115.61%-47.00K
-684.62%-306.00K
-16.67%270.00K
-196.25%-231.00K
+25.42%301.00K
+94.81%-39.00K
+180.00%324.00K
-Change in Receivables
+0.00%-4.00K
---4.00K
+400.00%3.00K
-100.00%0.00
-100.00%0.00
+100.00%0.00
-133.33%-1.00K
--1.00K
-40.00%3.00K
+50.00%-1.00K
+250.00%3.00K
+100.00%0.00
-16.67%5.00K
-166.67%-2.00K
-166.67%-2.00K
-400.00%-3.00K
+154.55%6.00K
+0.00%3.00K
-70.00%3.00K
+125.00%1.00K
-Change in Inventory
----
----
----
----
--0.00
----
----
----
--0.00
----
----
----
-100.00%0.00
-100.00%0.00
-114.29%-1.00K
-466.67%-11.00K
-66.67%1.00K
+300.00%4.00K
+600.00%7.00K
+112.00%3.00K
-Change in Prepaid Assets
-74.07%7.00K
-77.31%27.00K
-442.39%-499.00K
-72.82%28.00K
-300.00%-56.00K
+1800.00%119.00K
+22.03%-92.00K
+119.15%103.00K
-114.58%-14.00K
-118.92%-7.00K
+18.62%-118.00K
+74.07%47.00K
+295.92%96.00K
+3800.00%37.00K
-863.16%-145.00K
+50.00%27.00K
-16.67%-49.00K
-107.14%-1.00K
+533.33%19.00K
+157.14%18.00K
-Change in Payables and Accrued Expense
-103.16%-22.00K
+434.62%696.00K
+17.93%217.00K
+125.00%83.00K
-55.46%326.00K
+3.70%-208.00K
+4.55%184.00K
-160.14%-332.00K
+208.12%732.00K
-163.41%-216.00K
+211.39%176.00K
+114.79%552.00K
-258.20%-677.00K
-127.80%-82.00K
-132.35%-158.00K
-14.90%257.00K
-165.17%-189.00K
+31.11%295.00K
+91.12%-68.00K
+178.85%302.00K
Net cash flow from investing
--0.00
--0.00
--0.00
--0.00
---3.00K
+100.00%0.00
--0.00
--0.00
+100.00%0.00
+66.67%-4.00K
+100.00%0.00
--0.00
---2.00K
---12.00K
---1.00K
--0.00
--0.00
+100.00%0.00
----
----
Net Cash Flow from Continuing Investing Activities
--0.00
--0.00
--0.00
--0.00
---3.00K
+100.00%0.00
--0.00
--0.00
+100.00%0.00
+66.67%-4.00K
+100.00%0.00
--0.00
---2.00K
---12.00K
---1.00K
--0.00
--0.00
+100.00%0.00
----
----
Net PPE Purchase and Sale
--0.00
--0.00
--0.00
--0.00
---3.00K
+100.00%0.00
--0.00
--0.00
+100.00%0.00
+66.67%-4.00K
+100.00%0.00
--0.00
---2.00K
---12.00K
---1.00K
--0.00
--0.00
+100.00%0.00
----
----
Financing Cash Flow
-15.82%750.00K
+1813.46%891.00K
+2111.67%1.21M
-62.52%690.00K
-101.51%-61.00K
+11.86%-52.00K
-1.69%-60.00K
-74.51%1.84M
+6848.33%4.05M
-1.72%-59.00K
-100.68%-59.00K
+10273.24%7.22M
+11.76%-60.00K
+34.83%-58.00K
+13780.95%8.62M
-9.23%-71.00K
-101.38%-68.00K
-101.78%-89.00K
-103.15%-63.00K
-101.07%-65.00K
Net Cash Flow from Continuing Financing Activities
-15.82%750.00K
+1813.46%891.00K
+2111.67%1.21M
-62.52%690.00K
-101.51%-61.00K
+11.86%-52.00K
-1.69%-60.00K
-74.51%1.84M
+6848.33%4.05M
-1.72%-59.00K
-100.68%-59.00K
+10273.24%7.22M
+11.76%-60.00K
+34.83%-58.00K
+13780.95%8.62M
-9.23%-71.00K
-101.38%-68.00K
-101.78%-89.00K
-103.15%-63.00K
-101.07%-65.00K
Net Issuance Payments Of Debt
+251.55%2.61M
+1525.00%741.00K
+445.00%207.00K
+1289.66%690.00K
-3.39%-61.00K
+11.86%-52.00K
-1.69%-60.00K
+3.33%-58.00K
+1.67%-59.00K
-1.72%-59.00K
+13.24%-59.00K
+15.49%-60.00K
+11.76%-60.00K
+34.83%-58.00K
-7.94%-68.00K
-9.23%-71.00K
-13.33%-68.00K
---89.00K
---63.00K
---65.00K
Net Common Stock Issuance
-1336.67%-1.86M
--150.00K
--1.00M
-100.00%0.00
-100.00%0.00
--0.00
--0.00
-73.93%1.90M
--4.11M
--0.00
-100.00%0.00
--7.28M
--0.00
--0.00
--8.69M
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
Ending Cash Balance
+5.71%74.00K
-95.01%70.00K
-97.19%76.00K
-96.76%132.00K
-47.77%351.00K
+69.04%1.40M
-13.94%2.70M
-34.37%4.07M
-23.64%672.00K
-77.01%830.00K
-41.44%3.14M
+708.47%6.20M
-70.69%880.00K
-31.07%3.61M
-24.87%5.37M
-91.57%767.00K
-73.42%3.00M
-34.07%5.24M
+53.31%7.14M
+80.48%9.10M
Net Change in Cash
+650.00%33.00K
+99.54%-6.00K
+95.90%-56.00K
-106.44%-219.00K
-565.82%-1.05M
+43.73%-1.30M
+55.34%-1.37M
-36.14%3.40M
+94.21%-158.00K
-31.81%-2.31M
-166.53%-3.06M
+338.08%5.32M
-22.08%-2.73M
+7.78%-1.75M
+335.19%4.60M
-1.73%-2.24M
-166.84%-2.24M
-157.85%-1.90M
-411.78%-1.96M
-152.43%-2.20M
Beginning Cash Balance
-46.05%41.00K
-97.19%76.00K
-96.76%132.00K
-47.77%351.00K
+69.04%1.40M
-13.94%2.70M
-34.37%4.07M
-23.64%672.00K
-77.01%830.00K
-41.44%3.14M
+708.47%6.20M
-70.69%880.00K
-31.07%3.61M
-24.87%5.37M
-91.57%767.00K
-73.42%3.00M
-34.07%5.24M
+53.31%7.14M
+80.48%9.10M
+1228.59%11.29M
Free Cash Flow
+20.07%-717.00K
+28.18%-897.00K
+3.29%-1.26M
-158.38%-909.00K
+76.44%-991.00K
+44.56%-1.25M
+56.47%-1.31M
+181.86%1.56M
-57.51%-4.21M
-32.84%-2.25M
+25.39%-3.00M
+12.11%-1.90M
-23.14%-2.67M
+6.45%-1.70M
-112.53%-4.02M
-1.50%-2.16M
-36.16%-2.17M
-5.90%-1.81M
+20.57%-1.89M
-11.62%-2.13M
Deadline
Dec 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2024/Q42023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q32021/Q22021/Q12020/Q42020/Q32020/Q22020/Q12019/Q42019/Q32019/Q2
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of de-escalation in U.S.-Iran military tensions have emerged, pushing international oil prices lower. Trump ordered the U.S. military Show More